Newly approved pancreatic cancer drug shows promise in lung cancer
A groundbreaking pancreatic cancer drug shows promise against the most common form of lung cancer, according to clinical trial results published Wednesday in the New England Journal of Medicine.
Read more Iran says U.S. strike on wedding party killed at least 4 and injured dozens